A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19
Trial details
- Registry ID
- NCT05616728
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19NCT05616728 | ENTA | Phase 2 | Completed | 2023-02-08Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |